Novelix Pharmaceuticals Limited (BOM:536565)

India · Delayed Price · Currency is INR

60.03

+0.83 (1.40%)

At close: Oct 27, 2026

Market Cap	1.71B +123.1%
Revenue (ttm)	1.47B +180.4%
Net Income	36.29M +565.3%
EPS	1.50 +198.8%
Shares Out	28.47M
PE Ratio	39.99
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,473
Open	59.00
Previous Close	59.20
Day's Range	56.45 - 60.03
52-Week Range	46.01 - 92.00
Beta	0.25
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Novelix Pharmaceuticals

Novelix Pharmaceuticals Limited manufactures and trades pharmaceutical bulk drugs and related products in activities related to healthcare research, analytics, and technology in India. It also trades in shares and securities; retails pharmaceuticals; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India. [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries

Founded 1994

Employees 32

Stock Exchange Bombay Stock Exchange

Ticker Symbol 536565

Full Company Profile

Financial Performance

In fiscal year 2026, Novelix Pharmaceuticals's revenue was 1.32 billion, an increase of 330.60% compared to the previous year's 307.33 million. Earnings were 25.57 million, an increase of 2925.56%.

Financial Statements